Reduced expression of the small leucine-rich proteoglycans, lumican, and decorin is associated with poor outcome in node-negative invasive breast cancer

Clinical Cancer Research

Volumn 9, Issue 1 I, 2003, Pages 207-214

  Troup, Sandra ^a   Njue, Catherine ^a   Kliewer, Erich V ^a   Parisien, Michelle ^a   Roskelley, Cal ^b   Chakravarti, Shukti ^c   Roughley, Peter J ^d   Murphy, Leigh C ^a   Watson, Peter H ^a  

^a UNIVERSITY OF MANITOBA   (Canada)

^b UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^c JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d SHRINERS HOSPITAL FOR CHILDREN   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; DECORIN; ESTROGEN RECEPTOR; LUMICAN; PROGESTERONE RECEPTOR; PROTEOGLYCAN;

ADULT; AGED; ARTICLE; AXILLARY LYMPH NODE; BREAST CARCINOMA; CANCER ADJUVANT THERAPY; CANCER HORMONE THERAPY; CANCER INVASION; CANCER RECURRENCE; CANCER SURVIVAL; CONFIDENCE INTERVAL; CONTROLLED STUDY; CORRELATION ANALYSIS; FEMALE; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; TUMOR VOLUME; WESTERN BLOTTING;

BLOTTING, WESTERN; BREAST NEOPLASMS; DISEASE PROGRESSION; DISEASE-FREE SURVIVAL; ELECTROPHORESIS, POLYACRYLAMIDE GEL; EXTRACELLULAR MATRIX PROTEINS; FEMALE; HUMANS; IMMUNOBLOTTING; KERATAN SULFATE; LEUCINE; LYMPH NODES; PROGNOSIS; PROTEOCHONDROITIN SULFATES; PROTEOGLYCANS; TIME FACTORS; TREATMENT OUTCOME;

EID: 12244311868     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (48)

1. Morrow, M. Identification of the woman at risk for breast cancer: problem solved? Recent Results Cancer Res., 151: 85-95, 1999.
2. Silverstein, M. J., Lagios, M. D., Craig, P. H., Waisman, J. R., Lewinsky, B. S., Colburn, W. J., and Poller, D. N. A prognostic index for ductal carcinoma in situ of the breast. Cancer (Phila.), 77: 2267-2274, 1996.
3. Liotta, L. A. Tumor invasion and metastases: role of the basement membrane. Warner-Lambert Parke-Davis Award lecture. Am. J. Pathol., 117: 339-348, 1984.
4. Lochter, A., and Bissell, M. J. Involvement of extracellular matrix constituents in breast cancer. Semin. Cancer Biol., 6: 165-173, 1995.
5. Smith-Mungo, L. I., and Kagan, H. M. Lysyl oxidase: properties, regulation and multiple functions in biology. Matrix Biol., 16: 387-398, 1998.
6. Kivirikko, K. I. Collagens and their abnormalities in a wide spectrum of diseases. Ann. Med., 25: 113-126, 1993.
7. Kyriakides, T. R., Zhu, Y. H., Smith, L. T., Bain, S. D., Yang, Z., Lin, M. T., Danielson, K. G., Iozzo, R. V., LaMarca, M., McKinney, C. E., Ginns, E. I., and Bornstein, P. Mice that lack thrombospondin 2 display connective tissue abnormalities that are associated with disordered collagen fibrillogenesis, an increased vascular density, and a bleeding diathesis. J. Cell Biol., 140: 419-430, 1998.
8. Iozzo, R. V. The family of the small leucine-rich proteoglycans: key regulators of matrix assembly and cellular growth. Crit. Rev. Biochem. Mol. Biol., 32: 141-174, 1997.
9. Leygue, E., Snell, L., Dotzlaw, H., Hole, K., Hiller-Hitchcock, T., Roughley, P. J., Watson, P. H., and Murphy, L. C. Expression of lumican in human breast carcinoma. Cancer Res., 58: 1348-1352, 1998.
10. Leygue, E., Snell, L., Dotzlaw, H., Troup, S., Hiller-Hitchcock, T., Murphy, L. C., Roughley, P. J., and Watson, P. H. Lumican and decorin are differentially expressed in human breast carcinoma. J. Pathol., 192: 313-320, 2000.
11. Iozzo, R. V., and Cohen, I. Altered proteoglycan gene expression and the tumor stroma. Experientia, 49: 447-455, 1993.
12. Iozzo, R. V. Tumor stroma as a regulator of neoplastic behavior. Agonistic and antagonistic elements embedded in the same connective tissue. Lab. Investig., 73: 157-160, 1995.
13. Moscatello, D. K., Santra, M., Mann, D. M., McQuillan, D. J., Wong, A. J., and Iozzo, R. V. Decorin suppresses tumor cell growth by activating the epidermal growth factor receptor. J. Clin. Investig., 101: 406-412, 1998.
14. Iozzo, R. V., Chakrani, F., Perrotti, D., McQuillan, D. J., Skorski, T., Calabretta, B., and Eichstetter, I. Cooperative action of germ-line mutations in decorin and p53 accelerates lymphoma tumorigenesis. Proc. Natl. Acad. Sci. USA, 96: 3092-3097, 1999.
15. Watson, P. H., Snell, L., and Parisien, M. The NCIC-Manitoba Breast Tumor Bank: a resource for applied cancer research. CMAJ, 155: 281-283, 1996.
16. Cs-Szabo, G., Melching, L. I., Roughley, P. J., and Glant, T. T. Changes in messenger RNA and protein levels of proteoglycans and link protein in human osteoarthritic cartilage samples. Arthritis Rheum., 40: 1037-1045, 1997.
17. Grover, J., Chen, X. N., Korenberg, J. R., and Roughley, P. J. The human lumican gene. Organization, chromosomal location, and expression in articular cartilage. J. Biol. Chem., 270: 21942-21949, 1995.
18. Fox, S. B., Smith, K., Hollyer, J., Greenall, M., Hastrich, D., and Harris, A. L. The epidermal growth factor receptor as a prognostic marker: results of 370 patients and review of 3009 patients. Breast Cancer Res. Treat., 29: 41-49, 1994.
19. Harris, A. L., Nicholson, S., Sainsbury, J. R., Farndon, J., and Wright, C. Epidermal growth factor receptors in breast cancer: association with early relapse and death, poor response to hormones and interactions with neu. J. Steroid Biochem., 34: 123-131, 1989.
20. Bissell, M. J., Weaver, V. M., Lelievre, S. A., Wang, F., Petersen, O. W., and Schmeichel, K. L. Tissue structure, nuclear organization, and gene expression in normal and malignant breast. Cancer Res., 59: 1757-1763s, 1999.
21. Roskelley, C. D., and Bissell, M. J. Dynamic reciprocity revisited: a continuous, bidirectional flow of information between cells and the extracellular matrix regulates mammary epithelial cell function. Biochem. Cell Biol., 73: 391-397, 1995.
22. Gardner, H., Broberg, A., Pozzi, A., Laato, M., and Heino, J. Absence of integrin alpha1beta1 in the mouse causes loss of feedback regulation of collagen synthesis in normal and wounded dermis. J. Cell Sci., 112: 263-272, 1999.
23. Schlessinger, J. Direct binding and activation of receptor tyrosine kinases by collagen. Cell, 91: 869-872, 1997.
24. Roskelley, C. D., Desprez, P. Y., and Bissell, M. J. Extracellular matrix-dependent tissue-specific gene expression in mammary epithelial cells requires both physical and biochemical signal transduction. Proc. Natl. Acad. Sci. USA, 91: 12378-12382, 1994.
25. Santra, M., Skorski, T., Calabretta, B., Lattime, E. C., and Iozzo, R. V. De novo decorin gene expression suppresses the malignant phenotype in human colon cancer cells. Proc. Natl. Acad. Sci. USA, 92: 7016-7020, 1995.
26. Santra, M., Mann, D. M., Mercer, E. W., Skorski, T., Calabretta, B., and Iozzo, R. V. Ectopic expression of decorin protein core causes a generalized growth suppression in neoplastic cells of various histogenetic origin and requires endogenous p21, an inhibitor of cyclin-dependent kinases. J. Clin. Investig., 100: 149-157, 1997.
27. Iozzo, R. V., Moscatello, D. K., McQuillan, D. J., and Eichstetter, I, Decorin is a biological ligand for the epidermal growth factor receptor. J. Biol. Chem., 274: 4489-4492, 1999.
28. De Luca, A., Santra, M., Baldi, A., Giordano, A., and Iozzo, R. V. Decorin-induced growth suppression is associated with up-regulation of p21, an inhibitor of cyclin-dependent kinases. J. Biol. Chem., 271: 18961-18965, 1996.
29. Hildebrand, A., Romaris, M., Rasmussen, L. M., Heinegard, D., Twardzik, D. R., Border, W. A., and Ruoslahti, E. Interaction of the small interstitial proteoglycans biglycan, decorin and fibromodulin with transforming growth factor beta. Biochem. J., 302: 527-534, 1994.
30. Iozzo, R. V. The biology of the small leucine-rich proteoglycans. Functional network of interactive proteins. J. Biol. Chem., 274: 18843-18846, 1999.
31. Danielson, K. G., Baribault, H., Holmes, D. F., Graham, H., Kadler, K. E., and Iozzo, R. V. Targeted disruption of decorin leads to abnormal collagen fibril morphology and skin fragility. J. Cell Biol., 136: 729-743, 1997.
32. Chakravarti, S., Magnuson, T., Lass, J. H., Jepsen, K. J., LaMantia, C., and Carroll, H. Lumican regulates collagen fibril assembly: skin fragility and corneal opacity in the absence of lumican. J. Cell Biol., 141: 1277-1286, 1998.
33. Svensson, L., Aszodi, A., Reinholt, F. P., Fassler, R., Heinegard, D., and Oldberg, A. Fibromodulin-null mice have abnormal collagen fibrils, tissue organization, and altered lumican deposition in tendon. J. Biol. Chem., 274: 9636-9647, 1999.
34. Xu, T., Bianco, P., Fisher, L. W., Longenecker, G., Smith, E., Goldstein, S., Bonadio, J., Boskey, A., Heegaard, A. M., Sommer, B., Satomura, K., Dominguez, P., Zhao, C., Kulkarni, A. B., Robey, P. G., and Young, M. F. Targeted disruption of the biglycan gene leads to an osteoporosis-like phenotype in mice. Nat. Genet., 20: 78-82, 1998.
35. Weber, C. K., Sommer, G., Michl, P., Fensterer, H., Weimer, M., Gansauge, F., Leder, G., Adler, G., and Gress, T. M. Biglycan is overexpressed in pancreatic cancer and induces G1-arrest in pancreatic cancer cell lines. Gastroenterology, 121: 657-667, 2001.
36. Peyrol, S., Raccurt, M., Gerard, F., Gleyzal, C., Grimaud, J. A., and Sommer, P. Lysyl oxidase gene expression in the stromal reaction to in situ and invasive ductal breast carcinoma. Am. J. Pathol., 150: 497-507, 1997.
37. Akhurst, R. J., and Balmain. A. Genetic events and the role of TGF beta in epithelial tumour progression. J. Pathol., 187: 82-90, 1999.
38. Reiss, M., and Barcellos-Hoff, M. H. Transforming growth factor-beta in breast cancer: a working hypothesis. Breast Cancer Res. Treat., 45: 81-95, 1997.
39. Arteaga, C. L., Dugger, T. C., and Hurd, S. D. The multifunctional role of transforming growth factor (TGF)-beta s on mammary epithelial cell biology. Breast Cancer Res. Treat., 38: 49-56, 1996.
40. Arteaga, C. L., Koli, K. M., Dugger, T. C., and Clarke, R. Reversal of tamoxifen resistance of human breast carcinomas in vivo by neutralizing antibodies to transforming growth factor-beta. J. Natl. Cancer Inst., 91: 46-53, 1999.
41. Kolb, M., Margetts, P. J., Sime, P. J., and Gauldie, J. Proteoglycans decorin and biglycan differentially modulate TGF-beta-mediated fibrotic responses in the lung. Am. J. Physiol. Lung Cell Mol. Physiol., 280: L1327-L1334, 2001.
42. Fischer, J. W., Kinsella, M. G., Levkau, B., Clowes, A. W., and Wight, T. N. Retroviral overexpression of decorin differentially affects the response of arterial smooth muscle cells to growth factors. Arteriscler. Thromb. Vasc. Biol., 21: 777-784, 2001.
43. Markmann, A., Hausser, H., Schonherr, E., and Kresse, H, Influence of decorin expression on transforming growth factor-beta-mediated collagen gel retraction and biglycan induction, Matrix Biol., 19: 631-636, 2000.
44. Medina, D., Kittrell, F. S., Oborn, C. J., and Schwartz, M. Growth factor dependency and gene expression in preneoplastic mouse mammary epithelial cells. Cancer Res., 53: 668-674, 1993.
45. Genersch, E., Schneider, D. W., Sauer, G., Khazaie, K., Schuppan, D., and Lichtner, R. B. Prevention of EGF-modulated adhesion of tumor cells to matrix proteins by specific EGF receptor inhibition. Int. J. Cancer, 75: 205-209, 1998.
46. Verbeek, B. S., Adriaansen-Slot, S. S., Vroom, T. M., Beckers, T., and Rijksen, G. Overexpression of EGFR and c-erbB2 causes enhanced cell migration in human breast cancer cells and NIH3T3 fibroblasts. FEBS Lett., 425: 145-150, 1998.
47. Nicholson, S., Wright, C., Sainsbury, J. R., Halcrow, P., Kelly, P., Angus, B., Farndon, J. R., and Harris, A. L. Epidermal growth factor receptor (EGFr) as a marker for poor prognosis in node-negative breast cancer patients: neu and tamoxifen failure. J. Steroid Biochem. Mol. Biol., 37: 811-814, 1990.
48. Kerbel, R. S. New targets, drugs, and approaches for the treatment of cancer: an overview. Cancer Metastisis Rev., 17: 145-147, 1998.